Anti-nuclear antibody development is associated with poor treatment response to biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
Ishikawa, Yuki, Hashimoto, Motomu, Ito, Hiromu, Tanaka, Masao, Yukawa, Naoichiro, Fujii, Takao, Yamamoto, Wataru, Mimori, Tsuneyo, Terao, ChikashiLanguage:
english
Journal:
Seminars in Arthritis and Rheumatism
DOI:
10.1016/j.semarthrit.2019.02.003
Date:
February, 2019
File:
PDF, 861 KB
english, 2019